Tel Aviv Medical Center
Tel Aviv, Israel
7 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 2
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Parkinson DiseaseParkinsonParkinson Disease, Idiopathic+2 more
Neuron23 Inc.150 enrolled69 locationsNCT06680830
Recruiting
Phase 2
Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)
Parkinson Disease
Denali Therapeutics Inc.50 enrolled20 locationsNCT06602193
Recruiting
Phase 2Phase 3
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Advanced Melanoma
Eikon Therapeutics740 enrolled77 locationsNCT06697301
Recruiting
The ReTAVI Prospective Observational Registry
Structural Valve DeteriorationStructural Valve DegenerationSymptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure+2 more
Institut für Pharmakologie und Präventive Medizin250 enrolled62 locationsNCT05601453
Recruiting
Phase 1
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)
Non-Hodgkin LymphomaLymphomaLymphoma, Non-Hodgkin+4 more
Caribou Biosciences, Inc.72 enrolled38 locationsNCT04637763
Recruiting
Evaluation and Management of Cardio Toxicity in Oncologic Patients
Heart Failure
Tel-Aviv Sourasky Medical Center1,000 enrolled1 locationNCT02818517
Recruiting
Evaluation and Management of Heart Failure Patients
Heart Failure
Tel-Aviv Sourasky Medical Center5,000 enrolled1 locationNCT03142659